Literature DB >> 3695803

Dopamine receptors in human gastrointestinal mucosa.

D E Hernandez1, G A Mason, C H Walker, J E Valenzuela.   

Abstract

Dopamine is a putative enteric neurotransmitter that has been implicated in exocrine secretory and motility functions of the gastrointestinal tract of several mammalian species including man. This study was designed to determine the presence of dopamine binding sites in human gastric and duodenal mucosa and to describe certain biochemical characteristics of these enteric receptor sites. The binding assay was performed in triplicate with tissue homogenates obtained from healthy volunteers of both sexes using 3H-dopamine as a ligand. The extent of nonspecific binding was determined in the presence of a 100-fold excess of unlabeled dopamine. Scatchard analysis performed with increasing concentrations of 3H-dopamine (20-500 nM) revealed a single class of saturable dopamine binding sites in gastric and duodenal mucosa. Binding parameters obtained from the regression lines of the Scatchard plots of gastric mucosa of males were Bmax = 73.4 +/- 4.0 pmoles/mg protein; KD = 154 +/- 20 nM and Bmax = 95 +/- 13.6 pmoles/mg protein and KD = 826 +/- 200 nM in females. In duodenal mucosa of males these parameters were Bmax = 63.9 +/- 15.9 pmoles/protein; KD = 235 +/- 53 nM and Bmax = 83.2 +/- 19.4 pmoles/mg protein; KD = 568 +/- 104 nM in females. The results of this report demonstrate the presence of specific dopamine receptors in human gastric and duodenal mucosa. These biochemical data suggest that molecular abnormalities of these receptor sites may be operative in the pathogenesis of important gastrointestinal disorders.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3695803     DOI: 10.1016/0024-3205(87)90464-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  11 in total

1.  Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissue.

Authors:  S Basu; P S Dasgupta
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

2.  Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation.

Authors:  Subhalakshmi Ganguly; Biswarup Basu; Saurav Shome; Tushar Jadhav; Sudipta Roy; Jahar Majumdar; Partha Sarathi Dasgupta; Sujit Basu
Journal:  Am J Pathol       Date:  2010-11-12       Impact factor: 4.307

3.  Alteration of dopamine D2 receptors in human malignant stomach tissue.

Authors:  S Basu; P S Dasgupta
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

Review 4.  Dopamine in gastrointestinal disease.

Authors:  G B Glavin; S Szabo
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

5.  Increased dopamine receptor binding in duodenal mucosa of duodenal ulcer patients.

Authors:  D E Hernandez; C H Walker; J E Valenzuela; G A Mason
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

6.  Dopaminergic control of gastric mucosal blood flow in humans. A study with endoscopic laser Doppler flowmetry coupled with gastric submucosal drug injection.

Authors:  M Kaise; H Echizen; T Ishizaki
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

7.  Catecholamine concentrations in biopsied gastroduodenal tissue specimens of patients with duodenal ulcer.

Authors:  M Kaise; H Echizen; N Umeda; T Ishizaki
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

8.  Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial.

Authors:  Gwen Murphy; Amanda J Cross; Leah S Sansbury; Andrew Bergen; Adeyinka O Laiyemo; Paul S Albert; Zhuoqiao Wang; Binbing Yu; Teresa Lehman; Aravind Kalidindi; Rama Modali; Arthur Schatzkin; Elaine Lanza
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

9.  Plasma neurotransmitters and cortisol in duodenal ulcer patients. Role of stress.

Authors:  F Lechin; B van der Dijs; I Rada; H Jara; A E Lechin; A Cabrera; M E Lechin; V Jimènez; F Gòmez; S Villa
Journal:  Dig Dis Sci       Date:  1990-11       Impact factor: 3.199

10.  Enhancement of dopaminergic agonist bromocriptine of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.

Authors:  H Iishi; M Baba; M Tatsuta; S Okuda; H Taniguchi
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.